Emergent and J&J settle dispute over COVID vaccine supplies
Emergent BioSolutions said Monday that Johnson & Johnson has agreed to pay $50 million to settle claims related to a terminated COVID-19 vaccine deal. The company’s shares rose about 2 per cent in extended trading.
POPULAR POSTS
Pope Francis calls for action on climate change
September 6, 2024
Climate change costing Africa up to 5% of GDP, UN says
September 6, 2024
A forest fire has destroyed 20% of the forests in Brazil
September 6, 2024
Toronto Film Festival showcases an industry transformed by streaming
September 6, 2024
LIVE STREAM
